Synthesis and Consumption: a Focus on the PARP Family

Synthesis and Consumption: a Focus on the PARP Family

Downloaded from genesdev.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press SPECIAL SECTION: REVIEW Interplay between compartmentalized NAD+ synthesis and consumption: a focus on the PARP family Michael S. Cohen Department of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, Oregon 97210, USA Nicotinamide adenine dinucleotide (NAD+) is an essential erate a polymer of ADP-ribose (ADPr), a process known as cofactor for redox enzymes, but also moonlights as a sub- poly-ADP-ribosylation or PARylation (more on this below) strate for signaling enzymes. When used as a substrate by (Fig. 1; Chambon et al. 1963, 1966; Fujimura et al. 1967a,b). signaling enzymes, it is consumed, necessitating the recy- Unlike NAD+-mediated redox reactions, this glycosidic cling of NAD+ consumption products (i.e., nicotinamide) cleavage reaction is irreversible and leads to the consump- via a salvage pathway in order to maintain NAD+ homeo- tion of NAD+. Consistent with this notion, in the 1970s it stasis. A major family of NAD+ consumers in mammalian was shown that NAD+ exhibits a high turnover in human cells are poly-ADP-ribose-polymerases (PARPs). PARPs cells (Rechsteiner et al. 1976). We now know that there are comprise a family of 17 enzymes in humans, 16 of which many “NAD+ consumers” (e.g., other PARP family mem- catalyze the transfer of ADP-ribose from NAD+ to macro- ber, sirtuins, etc.) beyond PARP1, which are found in molecular targets (namely, proteins, but also DNA and nearly all subcellular compartments, including the nucle- RNA). Because PARPs and the NAD+ biosynthetic en- us, cytoplasm, and mitochondria (Fig. 1; Verdin 2015). zymes are subcellularly localized, an emerging concept Because of these NAD+ consumers, continuous synthesis is that the activity of PARPs and other NAD+ consumers of NAD+ is required for maintaining NAD+ levels. are regulated in a compartmentalized manner. In this re- Curiously, enzymes involved in NAD+ synthesis are lo- view, I discuss NAD+ metabolism, how different subcellu- calized to distinct subcellular compartments—like the lar pools of NAD+ are established and regulated, and how NAD+ consumers themselves—suggesting that NAD+-de- free NAD+ levels can control signaling by PARPs and re- pendent signaling is regulated in a compartmentalized dox metabolism. manner. In this review I discuss the interplay between NAD+ synthesis and consumption by NAD+ consumers, with a particular focus on PARPs because they are the largest family of NAD+ consumers in cells. I first discuss + + NAD metabolism (i.e., its synthesis and consumption). Nicotinamide adenine dinucleotide (NAD ): beyond I then discuss how NAD+ metabolism is compartmental- redox reactions ized. Last, I discuss how PARPs regulate—and are regulat- — + Nicotinamide adenine dinucleotide (NAD+) is found in all ed by changes in free NAD levels within subcellular living organisms and is essential for life. NAD+ was discov- compartments. ered by Sir Arthur Harden in 1906 and for the first half of the 20th century the only known role for NAD+ was as a coenzyme for redox reactions in metabolic processes How is NAD+ synthesized in cells? (e.g., glycolysis). In this capacity, NAD+ binds to oxidore- + ductase enzymes where it undergoes a two-electron reduc- NAD can be synthesized in mammalian cells from pre- tion to generate NADH and an oxidized substrate (Fig. 1). cursors via three major pathways: (1) synthesis from tryp- This reaction is catalytic and reversible (NADH is reoxi- tophan (the de novo pathway), (2) synthesis from nicotinic dized to NAD+); therefore, NAD+ is not consumed by re- acid (NA; Preiss-Handler pathway), and (3) synthesis from dox reactions in cells. However, in the mid-1960s NAD+ nicotinamide (NAM; salvage pathway) (Fig. 1). In humans, + was shown to be a substrate for a nuclear enzyme (now the major source of NAD is from NA and NAM, collec- known as poly-ADP-ribose-polymerase 1, PARP1) that tively referred to as niacin (vitamin B3). Niacin is essential cleaves the nicotinamide-glycosidic bond of NAD+ to gen- © 2020 Cohen This article is distributed exclusively by Cold Spring Har- bor Laboratory Press for the first six months after the full-issue publication [Keywords: ADP-ribosylation; biosensor; NAD; NAD consumer; PARP] date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six Corresponding author: [email protected] months, it is available under a Creative Commons License (Attribution- Article published online ahead of print. Article and publication date are NonCommercial 4.0 International), as described at http://creativecom- online at http://www.genesdev.org/cgi/doi/10.1101/gad.335109.119. mons.org/licenses/by-nc/4.0/. 254 GENES & DEVELOPMENT 34:254–262 Published by Cold Spring Harbor Laboratory Press; ISSN 0890-9369/20; www.genesdev.org Downloaded from genesdev.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press A focus on the PARP family Figure 1. Pathways of NAD+ synthesis, consumption, and redox chemistry. The dashed red line indicates cleav- age of the glycosidic bond of NAD+ by NAD+ consumers. NAD+ biosynthetic enzymes are shown in blue, NAD+ consumers are shown in red, and NAD+ redox enzymes are shown in green. (−) Inhibition; (+) activation. for maintaining NAD+ levels in vivo. Indeed, deficiencies phosphoribosyltransferase (NAMPT) and nicotinamide in niacin causes Pellagra, a metabolic disease that results mononucleotide adenylyltransferases (NMNAT) (Berger in diarrhea, dermatitis, dementia, and if untreated, death et al. 2005). NAMPT synthesizes nicotinamide mono- (Kirkland and Meyer-Ficca 2018). Hence, niacin is essen- nucleotide (NMN) from NAM and α-D-5-phospho- tial for the human diet. High levels of niacin are found ribosyl-1-pyrophosphate (PRPP) (Fig. 1; Revollo et al. in many foods, including meat, brown rice, and peanuts; 2007). NMNAT, which exists as three distinct genes however, because these niacin-rich foods were not com- (NMNAT1–3) that have nonoverlapping functions (more monplace in the American diet in the early part of the on this below), synthesizes NAD+ directly from NMN 20th century, especially in the South, grains were fortified and ATP (Fig. 1; Berger et al. 2005). Knockdown of with niacin beginning in the 1930s (Kirkland and Meyer- NAMPT, or inhibition of NAMPT activity using a small Ficca 2018). Recently, there has been much interest in us- molecule inhibitor (e.g., FK866, Fig. 1), substantially ing nicotinamide riboside (NR) to boost NAD+ levels in in reduces NAD+ levels in most cells (Liu et al. 2018). Con- vivo (Trammell et al. 2016). NR is a naturally occurring versely, treatment of cells with a small molecule activator NAD+ precursor that feeds into the salvage pathway (e.g., SBI-797812) (Fig. 1) of NAMPT increases NAD+ levels through the action of enzymes known as nicotinamide in cells (Gardell et al. 2019). Therefore, NAMPT is a criti- riboside kinase 1 and 2 (NRK1/2) (Fig. 1; Bieganowski cal regulator of NAD+ levels in many cultured cells. and Brenner 2004). Notwithstanding the importance of While NAMPT appears to be critical for maintaining dietary niacin and related NAD+ precursors, a recently NAD+ levels in many cells, NAD+ can be synthesized in published study found that in human patients the loss- an NAMPT-independent manner via the Preiss-Handler of-function mutations in enzymes in the de novo pathway. A recent study demonstrated that some cancer tryptophan-to-NAD+ pathway results in congenital mal- cells (e.g., OV4 ovarian cancer cells) are refractory to formations (Shi et al. 2017). In these patients, serum changes in NAD+ levels upon knockdown of NAMPT NAD+ levels were significantly lower, demonstrating (Chowdhry et al. 2019). In OV4 cells, enzymes in the Pre- that dietary tryptophan is also an important source of iss-Handler pathway (synthesis of NAD+ from NA) such NAD+ in vivo. Perhaps this result is not surprising consid- as nicotinate phosphoribosyltransferase (NAPRT) are am- ering the essentiality of NAD+ in human health. plified. NAPRT synthesizes nicotinic acid mononucleo- In many cells, the salvage pathway via the precursor tide (NAMN) from NA, and NAMN is subsequently NAM plays an essential role in maintaining physiological converted into nicotinic acid dinucleotide (NAAD+)by NAD+ levels in cells. NAD+ synthesis from NAM in NMNATs. Finally, NAAD+ is converted into NAD+ by mammalian cells requires two enzymes: nicotinamide NAD+ synthetase (NADS) (Fig. 1). Knockdown of NAPRT GENES & DEVELOPMENT 255 Downloaded from genesdev.cshlp.org on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press Cohen in OV4 cells, which were implanted subcutaneously in PARP family members (PARP3, PARP6–12, and nude mice, decreased tumor NAD+ levels and tumor vol- PARP14–16) catalyze the transfer of a single unit of ume. In contrast, knockdown of NAPRT in subcutaneous- ADPr to their targets, a process referred to as mono- ly implanted H460 lung cancer cells, which do not exhibit ADP-ribosylation (MARylation) (Vyas et al. 2014; Yang amplification of enzymes in the Preiss-Handler pathway, et al. 2017). SIRTs are NAD+-dependent deacylases did not alter NAD+ levels; rather, knockdown of NAMPT (Kosciuk et al. 2019), though some SIRT family members (or treatment with FK866) decreased tumor NAD+ levels (e.g., SIRT4,6) have been shown to also catalyze ADP- and tumor volume. Hence, cancer cells that have high lev- ribosylation (Liszt et al. 2005; Haigis et al. 2006). The els of NAPRT depend on the Preiss-Handler pathway for mechanism of sirtuin-mediated deacylation occurs via survival, whereas cancer cells that have low levels of an ADPr-lysine-imidate intermediate generated from the NAPRT depend on the salvage pathway. Cell type-depen- attack of an acyl oxygen of lysine at the anomeric position dent differences in NAD+ synthesis pathways have impor- of the nicotinamide ribose (Sauve et al. 2001). CD38 is a tant implications in cancer therapeutic strategies aimed transmembrane enzyme that cleaves NAD+ to generate at lowering NAD+ levels in cells.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    10 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us